Cargando…
Longitudinal Assessment of Plasma Syndecan-1 Predicts 60-Day Mortality in Patients with COVID-19
Background: Endotheliopathy is a common pathologic finding in patients with acute and long COVID-19. It may be associated with disease severity and predispose patients to long-term complications. Plasma levels of a proteoglycan, syndecan-1, are found to be significantly elevated in patients with COV...
Autores principales: | Zhang, Quan, Ye, Zhan, Bignotti, Antonia, Zheng, X. Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865511/ https://www.ncbi.nlm.nih.gov/pubmed/36675479 http://dx.doi.org/10.3390/jcm12020552 |
Ejemplares similares
-
Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19
por: Zhang, Quan, et al.
Publicado: (2022) -
Dynamic Assessment of Plasma von Willebrand Factor and ADAMTS13 Predicts Mortality in Hospitalized Patients with SARS-CoV-2 Infection
por: Zhang, Quan, et al.
Publicado: (2023) -
Effects of convalescent plasma infusion on the ADAMTS13-von Willebrand factor axis and endothelial integrity in patients with severe and critical COVID-19
por: Zhang, Quan, et al.
Publicado: (2022) -
Netosis and the Formation of Neutrophil Extracellular Traps (NETs) in Patients with Severe and Critical COVID-19 May Contribute to Disease Progression and Thrombosis
por: Yada, Noritaka, et al.
Publicado: (2022) -
Prognostic Value of Syndecan-1 in the Prediction of Sepsis-Related Complications and Mortality: A Meta-Analysis
por: Sun, Ting, et al.
Publicado: (2022)